April 2014

The pathologic analysis of lung cancer has become increasingly complex, calling for continued attention to improving the accuracy of the assessment and reducing the amount of tissue required.

At the 18th Annual International Congress on Hematologic Malignancies, Anas Younes, MD, sat down with Oncology & Biotech News to discuss trends in the management of hematologic malignances.

Medicine is undergoing a revolution that will transform the practice of healthcare, including oncology.

Epizyme, a Cambridge, Massachusetts-based biotech, opted for independence, with a successful IPO in 2013.

Lymphoma expert Andre Goy, MD, provides insight into the rapidly changing treatment landscape for patients with mantle cell lymphoma.